Description

Syndopa 275 is a medicine that combines two active ingredients, Levodopa and Carbidopa. Levodopa is a medication that helps to replenish dopamine levels in the brain, a chemical messenger that regulates movement and coordination. Carbidopa, on the other hand, is a peripheral dopa decarboxylase inhibitor that prevents the breakdown of Levodopa before it reaches the brain, allowing for more efficient absorption. Syndopa 275 is primarily used in the management of symptoms associated with Parkinson’s disease, a progressive nervous system disorder characterized by tremors, muscle stiffness, and balance problems. By increasing dopamine levels in the brain, Syndopa 275 helps to alleviate these symptoms, improving motor function and overall quality of life for individuals with Parkinson’s disease.

Additional information